Satellos Bioscience MSLE
NASDAQ MSLE
$8.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Net Preferred Shares Issued and Repurchased (2026)

Updated

Satellos Bioscience (MSLE) recorded Net Preferred Shares Issued and Repurchased of $4.65 million in the quarter ended Mar 31, 2026.

Analysis

Satellos Bioscience (MSLE) Net Preferred Shares Issued and Repurchased (2026) Analysis & Trends

For the year ended Dec 31, 2024, Satellos Bioscience reported Net Preferred Shares Issued and Repurchased of $6.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Satellos Bioscience 131.40 Mn 131.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 4.65 Mn
API Access

Satellos Bioscience Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=MSLE&period=max&api_key=YOUR_API_KEY